Home

ziar Se prelinge Regulament hepativ markers in fatty liver pub med singur Primul Maestru

Nonalcoholic fatty liver disease and mortality from all causes,  cardiovascular disease, and cancer: a meta-analysis | Scientific Reports
Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis | Scientific Reports

A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist  (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes  (T2D) | Scientific Reports
A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D) | Scientific Reports

Diagnostic and interventional circulating biomarkers in nonalcoholic  steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism -  Wiley Online Library
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library

Nonalcoholic Fatty Liver Disease: The Overlooked Complication of Type 2  Diabetes - Endotext - NCBI Bookshelf
Nonalcoholic Fatty Liver Disease: The Overlooked Complication of Type 2 Diabetes - Endotext - NCBI Bookshelf

A global view of the interplay between non-alcoholic fatty liver disease  and diabetes - The Lancet Diabetes & Endocrinology
A global view of the interplay between non-alcoholic fatty liver disease and diabetes - The Lancet Diabetes & Endocrinology

Non-alcoholic fatty liver disease publications and distribution of... |  Download Scientific Diagram
Non-alcoholic fatty liver disease publications and distribution of... | Download Scientific Diagram

Distinct contributions of metabolic dysfunction and genetic risk factors in  the pathogenesis of non-alcoholic fatty liver disease - Journal of  Hepatology
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - Journal of Hepatology

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes |  Diabetology & Metabolic Syndrome | Full Text
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology & Metabolic Syndrome | Full Text

Nonalcoholic Fatty Liver Disease: The Overlooked Complication of Type 2  Diabetes - Endotext - NCBI Bookshelf
Nonalcoholic Fatty Liver Disease: The Overlooked Complication of Type 2 Diabetes - Endotext - NCBI Bookshelf

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty  Liver (NAFL)-associated hepatocellular carcinoma - eBioMedicine
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma - eBioMedicine

Nonalcoholic Fatty Liver Disease | North Carolina Medical Journal
Nonalcoholic Fatty Liver Disease | North Carolina Medical Journal

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic  consequences, and treatment strategies - The Lancet Diabetes & Endocrinology
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology

Cureus | The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A  Systematic Review
Cureus | The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review

Frontiers | Gut Dysfunction and Non-alcoholic Fatty Liver Disease
Frontiers | Gut Dysfunction and Non-alcoholic Fatty Liver Disease

Current treatment of non‐alcoholic fatty liver disease - Paternostro - 2022  - Journal of Internal Medicine - Wiley Online Library
Current treatment of non‐alcoholic fatty liver disease - Paternostro - 2022 - Journal of Internal Medicine - Wiley Online Library

Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and  Challenges - Gastroenterology
Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges - Gastroenterology

Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver  Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

Cureus | A Multidisciplinary Approach and Current Perspective of  Nonalcoholic Fatty Liver Disease: A Systematic Review
Cureus | A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review

Biomedicines | Free Full-Text | Nonalcoholic Fatty Liver Disease (NAFLD):  Pathogenesis and Noninvasive Diagnosis | HTML
Biomedicines | Free Full-Text | Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis | HTML

Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease  (NAFLD) and the Role of Sugary Food Consumption and Other Dietary  Components in Its Development | HTML
Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development | HTML

Frontiers | Hepatic Macrophage as a Key Player in Fatty Liver Disease
Frontiers | Hepatic Macrophage as a Key Player in Fatty Liver Disease

IJMS | Free Full-Text | Mitochondrial Molecular Pathophysiology of  Nonalcoholic Fatty Liver Disease: A Proteomics Approach | HTML
IJMS | Free Full-Text | Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach | HTML

Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin  Resistance and Type 2 Diabetes
Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care  Providers - Mayo Clinic Proceedings
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings

Coagulation and Endothelial Dysfunction Associated with NAFLD: Current  Status and Therapeutic Implications
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications

Neutrophils in liver diseases: pathogenesis and therapeutic targets |  Cellular & Molecular Immunology
Neutrophils in liver diseases: pathogenesis and therapeutic targets | Cellular & Molecular Immunology

Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological  mechanisms shared between the two faces of the same coin
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin